Ophthalmology · Ladson, SC
NPI
1669966040
Since 2018
Specialty
Ophthalmology
Code 207W00000X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
9565 Highway 78 Bldg 200
Ladson, SC, 29456
Phone (843) 553-2477
Groups this clinician bills Medicare through
Medicare paid, 2024
$177K
2,107 services
Medicare patients, 2024
482
Average age 75
Drug cost, 2024
$154K
2,736 prescriptions
Company payments, 2025
$4,462
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rachel D Ellyn was code 99213 (office e&m - established), 333 times for 211 patients. In total Rachel D Ellyn billed 2,107 services in 32 codes, and Medicare paid $177K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-03-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 333 | 211 | $62.10 | $21K |
| 92133 Computerized Ophthalmic Imaging | Office | 254 | 246 | $23.61 | $5,998 |
| 99214 Office E&M - Established | Office | 231 | 164 | $90.79 | $21K |
| 99204 Office E&M - New | Office | 231 | 231 | $107.03 | $25K |
| 76514 Ultrasound - Nonspecific | Office | 175 | 175 | $6.91 | $1,209 |
| 92083 Vision, Hearing, and Speech Services | Office | 164 | 155 | $41.42 | $6,793 |
| 92020 Ophthalmological E&M | Office | 159 | 157 | $17.04 | $2,709 |
| 99203 Office E&M - New | Office | 103 | 103 | $64.21 | $6,613 |
| 92250 Angiography | Office | 93 | 91 | $25.75 | $2,395 |
| 92136 Ultrasound - Nonspecific | Office | 86 | 53 | $26.11 | $2,246 |
| 66984 Cataract Surgery | Facility | 74 | 45 | $356.53 | $26K |
| 65855 Fluid Flow and Drainage of Eye (Any Method) | Office | 56 | 40 | $172.88 | $9,681 |
| 92014 Ophthalmological E&M | Office | 20 | 20 | $93.32 | $1,866 |
| 66180 Fluid Flow and Drainage of Eye (Any Method) | Facility | 20 | 20 | $825.92 | $17K |
| 66710 Eye | Facility | 18 | 17 | $268.64 | $4,836 |
By year: 2022 $5,392 for 62 services; 2023 $35K for 420 services; 2024 $177K for 2,107 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rachel D Ellyn prescribed most often to Medicare patients was Latanoprost, with 481 prescriptions and refills. In total Rachel D Ellyn wrote 2,736 Medicare prescriptions that cost $154K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 481 | 1,231 | 197 | $5,222 |
| Prednisolone Acetate Generic | 431 | 491 | 197 | $22K |
| Brimonidine Tartrate Generic | 346 | 808 | 142 | $5,662 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 289 | 650 | 117 | $5,278 |
| Ofloxacin Generic | 202 | 221 | 122 | $2,701 |
| Atropine Sulfate Generic | 177 | 224 | 100 | $7,118 |
| Timolol Maleate Generic | 170 | 351 | 65 | $2,552 |
| Dorzolamide Hcl Generic | 159 | 340 | 55 | $2,952 |
| Ketorolac Tromethamine Generic | 84 | 88 | 51 | $2,213 |
| Erythromycin Erythromycin Base | 48 | 48 | 23 | $558 |
| Acetazolamide Generic | 47 | 59 | 17 | $4,943 |
| Lumigan Bimatoprost | 37 | 70 | 15 | $17K |
| Simbrinza Brinzolamide/Brimonidine Tart | 36 | 55 | Under 11 | $9,894 |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 29 | 57 | Under 11 | $3,932 |
| Rocklatan Netarsudil Mesylat/Latanoprost | 27 | 39 | Under 11 | $11K |
Brand drugs: 701 claims; generic drugs: 2,035 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rachel D Ellyn $4,462 ($4,462 in general payments such as food, travel and fees) from 17 companies. The largest payer was Bausch & Lomb Americas Inc. with $1,694.
| Company | Payments | Amount |
|---|---|---|
| Bausch & Lomb Americas Inc. BLCO | 7 | $1,694 |
| New World Medical,Inc. | 8 | $823 |
| Glaukos Corporation GKOS | 15 | $693 |
| Abbvie Inc. ABBV | 7 | $220 |
| Alcon Vision LLC ALC | 9 | $181 |
| Johnson & Johnson Surgical Vision, Inc. JNJ | 3 | $169 |
| Mallinckrodt Hospital Products Inc. | 5 | $122 |
| Tarsus Pharmaceuticals, Inc. TARS | 5 | $121 |
| Biotissue Holdings Inc. | 2 | $119 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 5 | $117 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.